期刊文献+

肝癌患者术后血浆与白蛋白联合输注的临床观察 被引量:2

The Clinical Observation of Albumin and Plasma Combining Transfusion for Patients with Hepatocelluar Carcinoma
原文传递
导出
摘要 目的探讨肝癌患者单纯输注白蛋白和联合输注白蛋白+新鲜冰冻血浆的临床疗效。方法68例肝癌患者随机份白蛋白组(34例)联合输注白蛋白+新鲜冰冻血浆组(34例)。排除门脉栓患者术后易出现肝功异常,大量腹水的出现,蛋白降低(〈30g/L)。联合组每天输注蛋白10g/L和新鲜冰冻血浆200ml,直到蛋白〉31g/L,腹水减少,食欲增加,大约需5~7d。蛋白组每天输注蛋白10~20g/L,约5~7d。结果两组有显著差异(P〈0.05),蛋白组提高蛋白有效率达90.8%,但肝功能(ALT)恢复较慢,大量腹水无变化。联合组提高蛋白有效率达96.78%,腹水明显减少,食欲增加,ALT指数降低,肝功能恢复较快。结论肝癌患者术后采用白蛋白和血浆联合输注,较快的提高了蛋白,有利益于肝功能的恢复,腹水明显减少,食欲增加,易于患者术后的恢复。 Objective To explore the clinical effects of albumin transfusion ( Group 1 ) and albumin combined with plasma( Group 2) transfusion for hepatocelluar carcinoma. Methods 2 groups were designed and each group had 34 cases of patients who after the operation to dislodge thrombus in portal vein and had some symtoms such as liver dysfuntion, ascite or decreased blood albumin( 〈 30 g/L). Group 1 were infused albumin at the dosage of 10 -20 g/d for 5-7 days,while Group 2 were insfused albumin for 10-20 g/d and freshly frozened plasma 200 mL/d for 5-7 days. Results There was significant difference between Group 1 and Group 2. In Group 1 ,blood albumin were effetively increased( 〉 30 g/L)by 90. 8% , while ALT recovered slowly and there were no obvious changes for ascite. In group 2 ,the effective ratio for raising albumin was 96. 78% ,ascite was reduced obviously, the count of of ALT and liver function recovered more quickly than Group 1 while provoking the appetite. Conclusion The combined transfusion of albumin and plasma may raise blood albumin effectively and be advantageous to liver functional recovery, reducing ascite and provoking the appetite. This treatment is favorable to support recovery after surgical operation.
出处 《中国临床实用医学》 2010年第8期53-54,共2页 China Clinical Practical Medicine
关键词 肝癌 白蛋白 血浆 Hepatocelluar carcinoma Albumin Plasma
  • 相关文献

参考文献3

二级参考文献29

  • 1Roberto Giulio Romanelli,Giorgio La Villa,Giuseppe Barletta,Francesco Vizzutti,Fabio Lanini,Umberto Arena,Vieri Boddi,Roberto Tarquini,Pietro Pantaleo,Paolo Gentilini,Giacomo Laffi.Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial[J].World Journal of Gastroenterology,2006,12(9):1403-1407. 被引量:24
  • 2李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 3汤钊猷 杨秉辉 等.肝癌研究概况与展望[M].北京:北京医科大学中国协和医科大学联合出版社,1993.4-15.
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5[1]Soni N.Wonderful albumin? BMJ,1995,310:887
  • 6[2]Boldt J.The good,the bad,and the ugly:should we completely banish human albumin from our intensive care units? Anesth Analg,2000,91(4):887
  • 7[3]Quaranta JF.Immediate and late complications of human albumin use.Ann Fr Anesth Reanim,1996,15(4):553
  • 8[4]Kaminski MV,Willians SD.Review of the rapid normalization of serum albumin with modified total parenteral nutrition solutions.Crit Care Med,1990,18:327
  • 9[5]Sibbald WJ.Fluid therapy in sepsis.In:Reinkart K,Eyrich K,Sprung C.eds.Sepsis-current perspectives in pathophysiology and therapy.Update in intensive care and emergency medicin.Vol 18.Berlin:Springer,1994,266~273
  • 10[6]Weil MH,Henning RJ,Puri VK.Colloid oncotic pressure:clinical significance.Crit Care Med,1979,7:113

共引文献143

同被引文献20

  • 1Ramser G. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor Vlla: an evidence-based re- view[J]. Best Pract Res CI Ha, 2006, 19(1): 113-126.
  • 2Hessien M, Ayad M, Ibrahim W M. Monitoring coagulation proteins during progression of liver disease[J]. Indian J Clin Biochem, 2014, 29(4):1-7.
  • 3Mintz P D, Bass N M, Petz L D, et al. Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagu- Iopathy of liver disease[J]. Blood, 2006, 107(9): 3753-3760.
  • 4Alvarez I, Reichenberg S, Di Nicola S. Plasma transfusion volume and liver transplantation safety[J]. Transfusion, 2013, 53(10): 2353- 2354.
  • 5Moiz B, Arif F M, Hashmi K Z. Appropriate and inappropriate use of fresh frozen plasma[J]. J Pak Med Assoc, 2006, 56(8): 356- 359.
  • 6Gaur P, Singh A K, Shukla N K, et al. Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral Cancer patients and their clinical significance[J]. Hum Immunol, 2014, 75(4): 330-337.
  • 7肖倩,黄旭峰.尿毒症合并贫血患者输注悬浮红细胞和红细胞生成素疗效对比研究[J].检验医学与临床,2009,6(13):1035-1036. 被引量:4
  • 8蒋礼.肝肾综合征的治疗进展[J].中华全科医学,2010,8(6):767-769. 被引量:4
  • 9周立红,刘泽霖.凝血试验异常及凝血性疾病患者血浆及冷沉淀的合理使用[J].血栓与止血学,2010,16(4):187-189. 被引量:14
  • 10吴志美,袁建芬,苏敏.慢性肾衰竭患者止凝血功能的变化[J].检验医学与临床,2011,8(1):32-33. 被引量:2

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部